menu
    • menu

    Company profile for Psyence Biomed

    NEW Drugs in Dev: 1
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Psyence Biomed Ltd. is a pioneering Nasdaq-listed biopharmaceutical company focused on botanical psychedelics. As the world’s first nature-derived psilocybin biopharma on Nasdaq, we are committed to developing innovative, evidence-based treatments. Led by CEO Dr. Neil Maresky, MD, a renowned R&D leader with experience at AstraZeneca, Wyeth, and Bayer, our physician-driven approach ensures patient-centered solutions. With a t...
    Psyence Biomed Ltd. is a pioneering Nasdaq-listed biopharmaceutical company focused on botanical psychedelics. As the world’s first nature-derived psilocybin biopharma on Nasdaq, we are committed to developing innovative, evidence-based treatments. Led by CEO Dr. Neil Maresky, MD, a renowned R&D leader with experience at AstraZeneca, Wyeth, and Bayer, our physician-driven approach ensures patient-centered solutions. With a track record of bringing 50+ medicines to market, Psyence combines “psychedelics” and “science” to transform mental health and wellness through groundbreaking therapies.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Psyence BiomedCanada Flag
    Country
    Country
    Canada
    Address
    Address
    121 Richmond Street West, Penthouse Suite, 1300, Toronto ON M5H2K1
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://psyencebiomed.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Clinical Outsourcing

    Clinical Outsourcing

    Not Confirmed

    envelop Contact Supplier

    Clinical Outsourcing

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Psyence Biomed Reveals Shareholders Meeting Outcomes
    Psyence Biomed Reveals Shareholders Meeting Outcomes

    17 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/17/3239402/0/en/Psyence-BioMed-Announces-Results-of-Annual-and-Special-Meeting-of-Shareholders.html

    GLOBENEWSWIRE
    17 Feb 2026
    Share Share
    Psyence Biomed Approves Put Option Agreement With Psylabs
    Psyence Biomed Approves Put Option Agreement With Psylabs

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238373/0/en/Psyence-BioMed-Approves-Put-Option-Agreement-with-PsyLabs-to-Secure-Strategic-Supply-and-Strengthen-Commercialization-Pathway.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    Psyence Biomed Announces Settlement Of Shareholder Litigation
    Psyence Biomed Announces Settlement Of Shareholder Litigation

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236371/0/en/Psyence-BioMed-Announces-Settlement-of-Shareholder-Litigation.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share
    Psyence Biomed Sets Date For 1-For-6.25 Reverse Stock Split
    Psyence Biomed Sets Date For 1-For-6.25 Reverse Stock Split

    28 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/28/3228135/0/en/Psyence-BioMed-Announces-Effective-Date-for-1-for-6-25-Reverse-Stock-Split.html

    GLOBENEWSWIRE
    28 Jan 2026
    Share Share
    Psyence Biomed Adjourns AGM to Jan. 22, 2026
    Psyence Biomed Adjourns AGM to Jan. 22, 2026

    22 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/22/3224201/0/en/Psyence-BioMed-Announces-Adjournment-of-Annual-and-Special-Shareholder-Meeting-on-January-22-2026.html

    GLOBENEWSWIRE
    22 Jan 2026
    Share Share
    Psyence Biomed Delays Reverse Stock Split Implementation
    Psyence Biomed Delays Reverse Stock Split Implementation

    20 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/20/3221584/0/en/Psyence-BioMed-Announces-Postponement-of-Previously-Announced-Reverse-Stock-Split-Effective-Date.html

    GLOBENEWSWIRE
    20 Jan 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search